Olfactomedin-4 Positive Neutrophils: Link to Bronchopulmonary Dysplasia
Sunday, April 24, 2022
9:00 AM – 9:15 AM US MT
Location: Convention Center: Mile High Ballroom 1AB
CE: Enduring CME: 0.25
Publication Number: 2160.5
Faris N. Al Gharaibeh, Cincinnati Children's Hospital Medical Center, cincinnati, OH, United States; Kristalynn M. Kempton, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Hector Wong, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Matthew N. Alder, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States
Presenting Author(s)
Faris N. Al Gharaibeh, MD
Clinical Fellow Cincinnati Children's Hospital Medical Center cincinnati, Ohio, United States
Participants should be aware of the following financial/non-financial relationships:
Faris N. Al Gharaibeh, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Kristalynn M. Kempton, BS, BA, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Hector Wong, MD: ● "Company" is not applicable. Hector Wong and the Cincinnati Children's Research Foundation hold U.S. patents for the PERSEVERE biomarkers. (Currently Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties).
Matthew N. Alder, M.D., Ph.D: I do not have any relevant financial / non-financial relationships with any proprietary interests.
.jpg "Faris N. Al Gharaibeh, MD photo")